About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNCT05215964

The Association Between Skeletal Muscle Mass and Severity of Polycystic Liver Disease and Polycystic Kidney Disease

Primary sarcopenia is used to describe aging and progressed with the physiologic decline. Secondary sarcopenia is associated many chronic disease, including acquired immune deficiency syndrome, cancer...

Lead sponsor: National Taiwan University Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

National Taiwan University Hospital

The imaging study (CT or MRI) will be performed within one month before the procedure to measure total kidney volume and psoas muscle area. The procedure will use transcatheter embolization to renal artery. The follow-up imaging study will be performed six months after the procedure to measure total kidney volume and psoas muscle area..

Age

20 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Polycystic related disease with medical images (CT or MRI) diagnosed
•Aged over 20 years

Exclusion Criteria

•Lack of Bio-exam or medical images
•Pregnancy

Related studies

RECRUITINGPhase 2

A Study of the Effect of (S)-Pindolol Benzoate (ACM-001.1) on Lean Body Mass (LBM) in Obese Patents During (PROACT 1), and Post-semaglutide Therapy (PROACT 2)

NCT07101939 · Obesity, Muscle Loss

Testing LiverWatch, a Home-Based Remote-Monitoring Intervention for Advanced Liver Disease

NCT06136221 · Cirrhosis, Liver, End Stage Liver DIsease, and more

Effects of Exogenous Ketosis on Proteinuria and Renal Function

NCT06867471 · Renal Insufficiency, Chronic, Polycystic Kidney Diseases, and more

Galactooligosaccharide and Aging

NCT06411964 · Muscle Loss

YOOMI: Effect of Gamified Physical Therapy Exercise Software on Inpatient Mobility

NCT05815017 · Weakness, Muscle, Delirium in Old Age, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 31, 2022Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment600

Start dateSep 2020

Last updatedJan 31, 2022

Condition

Polycystic Kidney Diseases Polycystic Liver Disease Muscle Loss

Locations shown

NTUH

Taipei

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 31, 2022Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions